LESLEY BALLANCE: Open Payments
NPI 1033570015 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 34 payments from 21 companies in 2025. Trend: 2023 $12,822 · 2024 $7,209 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $107 |
| Incyte Corporation | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| PharmaEssentia USA Corporation | 2 | $56 |
| Exelixis Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 1 | $46 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $45 |
| TerSera Therapeutics LLC | 2 | $44 |
| Legend Biotech USA Inc. | 1 | $43 |
Products named: EPKINLY, REBLOZYL, LIBTAYO, BESREMI, CABOMETYX, JAKAFI, NERLYNX, Zoladex.
Industry payments across TN — which companies pay providers there.
